ARCHIVED 1. List of Drugs for Exceptional Importation and Sale [2020-04-30]

Notice to Reader:

This is an archived list. Please refer to the most current version of this list.

Drugs included on this list are called “designated drugs” and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.

Supersedes: 2020-04-06
Date issued: 2020-04-16

Access archived versions of this list.

designated drugs
Drug or Class of Drug; Brand Name, Medicinal Ingredient(s) Dosage Form, Strength, Route of Administration Country of Origin and Identifying Code Name of Importer Batch Number Date
Propofol; Fresenius Propoven, propofol Emulsion for injection or infusion, 100mL vial - 20mg/mL (2%), Intravenous Austria and Sweden, Inner vial label: M080395
Outer box label: M080396
Package leaflet: M080510
Fresenius Kabi Canada Ltd. N/A April 16, 2020
Midazolam;
Midazolam Injection, USP 2 mg / 2 mL (1 mg / mL),
Midazolam
Solution for injection,
1 mg/1 mL,
Intravenous and Intermuscular use
USA, ANDA 203460 Fresenius Kabi Canada Ltd. N/A April 17, 2020
Ceftriaxone;
Ceftriaxone for Injection USP 1g,
Ceftriaxone
Powder,
1g,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 00409-7332-01
Pfizer Canada ULC N/A April 17, 2020
Ketamine;
Ketamine Hydrochloride Injection USP 500mg/5mL,
Ketamine Hydrochloride
Solution -concentrate,
100mg/mL,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 00409-2051-05
Pfizer Canada ULC N/A April 17, 2020
Norepinephrine;
Levophed Injection USP 4mg/4mL,
Norepinephrine Bitartrate
Solution -concentrate,
1mg/mL,
Intravenous infusion following dilution
United States,
National Drug Code (NDC): 00409-3375-04
Pfizer Canada ULC N/A April 17, 2020
Midazolam;
Midazolam Injection USP 2mg/2mL,
Midazolam
Solution,
1mg/mL,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 00409-2305-17
Pfizer Canada ULC N/A April 17, 2020
Midazolam;
Midazolam Injection USP 5mg/5mL,
Midazolam
Solution,
1mg/mL,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 00409-2305-05
Pfizer Canada ULC N/A April 17, 2020
Midazolam;
Midazolam Injection USP 10mg/10mL,
Midazolam
Solution,
1mg/mL,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 0409-2587-05
Pfizer Canada ULC N/A April 17, 2020
Pancuronium;
Pancuronium Bromide Injection USP 10mg/10mL,
Pancuronium Bromide
Solution,
1mg/mL,
Intravenous use only
United States,
National Drug Code (NDC): 00409-4646-01
Pfizer Canada ULC N/A April 17, 2020
Dexmedetomidine;
Precedex injection 200mcg/2mL,
Dexmedetomidine Hydrochloride
Solution -concentrate,
100mcg/mL,
Intravenous use
United States,
National Drug Code (NDC): 00409-1638-02
Pfizer Canada ULC N/A April 17, 2020
Dexmedetomidine;
Precedex injection 400mcg/100mL,
Dexmedetomidine Hydrochloride
Solution,
4mcg/mL,
Intravenous use
United States,
National Drug Code (NDC): 00409-1660-10
Pfizer Canada ULC N/A April 17, 2020
Succinylcholine Chloride;
Quelicin Injection USP 200mg/10mL,
Succinylcholine Chloride
Solution,
20mg/mL,
Intramuscular or Intravenous use
United States,
National Drug Code (NDC): 00409-6629-02
Pfizer Canada ULC N/A April 17, 2020
Rocuronium;
Rocuronium Bromide injection 100mg/10mL,
Rocuronium Bromide
Solution,
10mg/mL,
Intravenous use only
United States,
National Drug Code (NDC): 00409-9558-10
Pfizer Canada ULC N/A April 17, 2020
Vecuronium;
Vecuronium Bromide for Injection 10mg,
Vecuronium Bromide
Powder for solution,
Intravenous use only
United States,
National Drug Code (NDC): 00409-1632-01
Pfizer Canada ULC N/A April 17, 2020

Page details

Date modified: